These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21264112)

  • 1. Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug Delivery.
    Shastri D; Patel L; Parikh R
    J Young Pharm; 2010 Apr; 2(2):116-20. PubMed ID: 21264112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate.
    Gupta S; Vyas SP
    Sci Pharm; 2010; 78(4):959-76. PubMed ID: 21179328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride.
    Mandal S; Thimmasetty MK; Prabhushankar G; Geetha M
    Int J Pharm Investig; 2012 Apr; 2(2):78-82. PubMed ID: 23119236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
    Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
    Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride.
    Makwana SB; Patel VA; Parmar SJ
    Results Pharma Sci; 2016; 6():1-6. PubMed ID: 26949596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
    Pawar P; Kashyap H; Malhotra S; Sindhu R
    Biomed Res Int; 2013; 2013():341218. PubMed ID: 23762839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride.
    Nanjwade BK; Deshmukh RV; Gaikwad KR; Parikh KA; Manvi FV
    Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):117-23. PubMed ID: 22015966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.
    Shastri DH; Prajapati ST; Patel LD
    Curr Drug Deliv; 2010 Jul; 7(3):238-43. PubMed ID: 20497100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of thermosensitive flurbiprofen
    Maddiboyina B; Jhawat V; Desu PK; Gandhi S; Nakkala RK; Singh S
    J Biomater Sci Polym Ed; 2021 Aug; 32(12):1584-1597. PubMed ID: 33977874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of levofloxacin loaded
    Jain P; Jaiswal CP; Mirza MA; Anwer MK; Iqbal Z
    Drug Dev Ind Pharm; 2020 Jan; 46(1):50-56. PubMed ID: 31818154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
    Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
    Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on Poloxamer Based Mucoadhesive Insitu Ophthalmic Hydrogel of Moxifloxacin HCL.
    Shastri DH; Prajapati ST; Patel LD
    Curr Drug Deliv; 2010 Feb; ():. PubMed ID: 20158483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate.
    El-Kamel AH
    Int J Pharm; 2002 Jul; 241(1):47-55. PubMed ID: 12086720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
    Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
    Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
    Khan N; Aqil M; Imam SS; Ali A
    Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting on
    Al Gawhari FJ
    J Adv Pharm Technol Res; 2023; 14(4):294-298. PubMed ID: 38107457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermosensitive
    Gözcü S; Polat KH
    Turk J Pharm Sci; 2023 May; 20(2):78-83. PubMed ID: 37161283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
    Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
    Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
    Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
    Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of xanthan gum and guar gum on in situ gelling ophthalmic drug delivery system based on poloxamer-407.
    Bhowmik M; Kumari P; Sarkar G; Bain MK; Bhowmick B; Mollick MM; Mondal D; Maity D; Rana D; Bhattacharjee D; Chattopadhyay D
    Int J Biol Macromol; 2013 Nov; 62():117-23. PubMed ID: 23988556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.